CREDIT SUISSE AG/ - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 169 filers reported holding BRIDGEBIO PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$19,058,628
+44.1%
722,739
-6.0%
0.02%
+46.2%
Q2 2023$13,222,431
+8.8%
768,746
+4.9%
0.01%
+8.3%
Q1 2023$12,150,289
+207.8%
732,828
+41.4%
0.01%
+200.0%
Q4 2022$3,947,929
-34.8%
518,101
-14.9%
0.00%
-42.9%
Q3 2022$6,054,000
+16.4%
609,028
+6.4%
0.01%
+40.0%
Q2 2022$5,199,000
-16.8%
572,570
-7.0%
0.01%0.0%
Q1 2022$6,247,000
-44.1%
615,525
-8.1%
0.01%
-16.7%
Q4 2021$11,171,000
-49.0%
669,736
+43.4%
0.01%
-50.0%
Q3 2021$21,895,000
-8.4%
467,126
+19.2%
0.01%
-7.7%
Q2 2021$23,897,000
+5.7%
392,008
+6.8%
0.01%
+8.3%
Q1 2021$22,605,000
-6.2%
366,979
+8.2%
0.01%0.0%
Q4 2020$24,111,000
+39.1%
339,060
-26.6%
0.01%
+9.1%
Q3 2020$17,338,000
-2.8%
462,087
-15.5%
0.01%
-15.4%
Q2 2020$17,838,000
+6008.9%
547,001
+5339.5%
0.01%
Q1 2020$292,000
-62.6%
10,056
-54.8%
0.00%
-100.0%
Q4 2019$780,000
+11.3%
22,232
-14.5%
0.00%0.0%
Q2 2019$701,00026,0000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders